labetalol hydrochloride 200 MG Oral Tablet

INDICATIONS AND USAGE Labetalol hydrochloride tablets, USP are indicated in the management of hypertension. Labetalol hydrochloride tablets, USP may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics.

Actavis Pharma, Inc.

FDA Reported Adverse Reactions
`[1] diarrhoea` `[2] drug ineffective` `[3] off label use` `[4] dyspnoea` `[5] nausea` `[6] fatigue` `[7] acute kidney injury` `[8] vomiting` `[9] death` `[10] pyrexia`

8 months ago

ROUND WHITE WATSON 606

HOW SUPPLIED Labetalol HCl Tablets, USP 100 mg are available as round, beige, film-coated tablets debossed with “ WATSON 605 ” on one side and scored on the other side. They are supplied in bottles of 100, 500, 1000. Labetalol HCl Tablets, USP 200 mg are available as round, white, film-coated tablets debossed with “ WATSON 606 ” on one side and scored on the other side. They are supplied in bottles of 100, 500, 1000. Labetalol HCl Tablets, USP 300 mg are available as round, blue, film-coated tablets debossed with “ WATSON 607 ” on one side and plain on the other side. They are supplied in bottles of 100, 500, 1000. Labetalol HCl Tablets, USP should be stored between 2 ° to 30°C (36° to 86° F). Dispense in a tight, light resistant container as defined in USP/NF. Brands listed are trademarks of their respective owners. Manufactured by: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Revised: December 2015

More pills like ROUND WATSON 606

Related Pills

labetalol hydrochloride 100 MG Oral Tablet

actavis pharma, inc.

labetalol hydrochloride tablet film coated

actavis pharma, inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site